| Entry |
|
| Name |
Amplified ERBB2 to RAS-ERK signaling pathway
|
| Definition |
EGF -> (ERBB2*+EGFR) -> GRB2 -> SOS -> RAS -> RAF -> MEK -> ERK |
| Expanded |
1950 -> (2064v3+1956) -> 2885 -> (6654,6655) -> (3265,3845,4893) -> (369,673,5894) -> (5604,5605) -> (5594,5595) |
| Class |
|
| Type |
Variant
|
| Pathway |
|
| Disease |
|
| Gene |
| 1950 | EGF; epidermal growth factor |
| 2064 | ERBB2; erb-b2 receptor tyrosine kinase 2 |
| 1956 | EGFR; epidermal growth factor receptor |
| 2885 | GRB2; growth factor receptor bound protein 2 |
| 6654 | SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 |
| 6655 | SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 |
| 3265 | HRAS; HRas proto-oncogene, GTPase |
| 3845 | KRAS; KRAS proto-oncogene, GTPase |
| 4893 | NRAS; NRAS proto-oncogene, GTPase |
| 369 | ARAF; A-Raf proto-oncogene, serine/threonine kinase |
| 673 | BRAF; B-Raf proto-oncogene, serine/threonine kinase |
| 5894 | RAF1; Raf-1 proto-oncogene, serine/threonine kinase |
| 5604 | MAP2K1; mitogen-activated protein kinase kinase 1 |
| 5605 | MAP2K2; mitogen-activated protein kinase kinase 2 |
| 5594 | MAPK1; mitogen-activated protein kinase 1 |
| 5595 | MAPK3; mitogen-activated protein kinase 3 |
|
| Variant |
2064v3 (ERBB2*) ERBB2 amplification
|
| Reference |
|
| Authors |
Ciardiello F, Tortora G |
| Title |
EGFR antagonists in cancer treatment. |
| Journal |
|
| Reference |
|
| Authors |
Riquelme I, Saavedra K, Espinoza JA, Weber H, Garcia P, Nervi B, Garrido M, Corvalan AH, Roa JC, Bizama C |
| Title |
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. |
| Journal |
|
| Reference |
|
| Authors |
Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA |
| Title |
Gastric cancer-molecular and clinical dimensions. |
| Journal |
|
| Reference |
|
| Authors |
Bertotti A, Sassi F |
| Title |
Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies. |
| Journal |
|
| LinkDB |
|